SE460945B - En multipel-unit-dos komposition av furosemid - Google Patents

En multipel-unit-dos komposition av furosemid

Info

Publication number
SE460945B
SE460945B SE8700137A SE8700137A SE460945B SE 460945 B SE460945 B SE 460945B SE 8700137 A SE8700137 A SE 8700137A SE 8700137 A SE8700137 A SE 8700137A SE 460945 B SE460945 B SE 460945B
Authority
SE
Sweden
Prior art keywords
release
hour
furosemide
aqueous medium
composition
Prior art date
Application number
SE8700137A
Other languages
English (en)
Swedish (sv)
Other versions
SE8700137D0 (sv
SE8700137L (sv
Inventor
C H Appelgren
E C Eskilsson
Original Assignee
Lejus Medical Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lejus Medical Ab filed Critical Lejus Medical Ab
Priority to SE8700137A priority Critical patent/SE460945B/sv
Publication of SE8700137D0 publication Critical patent/SE8700137D0/xx
Priority to EP88850006A priority patent/EP0277925A1/en
Priority to NO880158A priority patent/NO880158L/no
Priority to CA000556485A priority patent/CA1292684C/en
Priority to FI880158A priority patent/FI880158A/fi
Priority to DK015988A priority patent/DK15988A/da
Priority to US07/144,229 priority patent/US4888179A/en
Publication of SE8700137L publication Critical patent/SE8700137L/
Publication of SE460945B publication Critical patent/SE460945B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SE8700137A 1987-01-15 1987-01-15 En multipel-unit-dos komposition av furosemid SE460945B (sv)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SE8700137A SE460945B (sv) 1987-01-15 1987-01-15 En multipel-unit-dos komposition av furosemid
EP88850006A EP0277925A1 (en) 1987-01-15 1988-01-13 Diuretic composition
NO880158A NO880158L (no) 1987-01-15 1988-01-14 Diuretisk blanding.
CA000556485A CA1292684C (en) 1987-01-15 1988-01-14 Diuretic composition containing furosemide
FI880158A FI880158A (fi) 1987-01-15 1988-01-14 Diuretisk komposition.
DK015988A DK15988A (da) 1987-01-15 1988-01-14 Diuretisk praeparat
US07/144,229 US4888179A (en) 1987-01-15 1988-01-15 Diuretic composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8700137A SE460945B (sv) 1987-01-15 1987-01-15 En multipel-unit-dos komposition av furosemid

Publications (3)

Publication Number Publication Date
SE8700137D0 SE8700137D0 (sv) 1987-01-15
SE8700137L SE8700137L (sv) 1988-07-16
SE460945B true SE460945B (sv) 1989-12-11

Family

ID=20367173

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8700137A SE460945B (sv) 1987-01-15 1987-01-15 En multipel-unit-dos komposition av furosemid

Country Status (7)

Country Link
US (1) US4888179A (da)
EP (1) EP0277925A1 (da)
CA (1) CA1292684C (da)
DK (1) DK15988A (da)
FI (1) FI880158A (da)
NO (1) NO880158L (da)
SE (1) SE460945B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1246382B (it) * 1990-04-17 1994-11-18 Eurand Int Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon
US6764697B1 (en) 1991-06-27 2004-07-20 Alza Corporation System for delaying drug delivery up to seven hours
US5609884A (en) * 1992-08-31 1997-03-11 G. D. Searle & Co. Controlled release naproxen sodium plus naproxen combination tablet
US5358502A (en) * 1993-02-25 1994-10-25 Pfizer Inc PH-triggered osmotic bursting delivery devices
US5760069A (en) * 1995-02-08 1998-06-02 Boehringer Mannheim Pharmaceuticals Corporation-Smithkline Beecham Corporation Limited Partnership #1 Method of treatment for decreasing mortality resulting from congestive heart failure
WO1998027967A1 (en) * 1996-12-20 1998-07-02 Dumex-Alpharma A/S Release-controlled coated tablets
US5891474A (en) 1997-01-29 1999-04-06 Poli Industria Chimica, S.P.A. Time-specific controlled release dosage formulations and method of preparing same
US5788987A (en) * 1997-01-29 1998-08-04 Poli Industria Chimica Spa Methods for treating early morning pathologies
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
CA2440641A1 (en) 2001-03-13 2002-09-19 Anand R. Baichwal Chronotherapeutic dosage forms containing glucocorticosteroid
AP2006003585A0 (en) 2003-09-19 2006-04-30 Penwest Pharmaceuticals Co Delayed release dosage forms.
EP1686986A4 (en) * 2003-11-25 2009-05-27 Sb Pharmco Inc CARVEDILOL SALTS, CORRESPONDING COMPOSITIONS, METHODS OF ADMINISTRATION AND / OR TREATMENT
EP1749519A1 (de) * 2005-08-05 2007-02-07 Schering Aktiengesellschaft Arzneiform mit Retardtierter pH-unabhängiger Wirkstofffreisetzung für Wirkstoffe mit starker pH-abhängiger Löslichkeit
US20070087056A1 (en) * 2005-08-09 2007-04-19 Claudia Guthmann Pharmaceutical form with sustained pH-independent active ingredient release for active ingredients having strong pH-dependent solubility
CA2624933A1 (en) * 2005-10-04 2007-04-12 Nitromed, Inc. Methods for treating respiratory disorders

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD146547A5 (de) * 1978-07-15 1981-02-18 Boehringer Sohn Ingelheim Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
IE59287B1 (en) * 1984-02-10 1994-02-09 Benzon Pharma As Diffusion coated multiple-units dosage form
US4728512A (en) * 1985-05-06 1988-03-01 American Home Products Corporation Formulations providing three distinct releases
AU591248B2 (en) * 1986-03-27 1989-11-30 Kinaform Technology, Inc. Sustained-release pharaceutical preparation

Also Published As

Publication number Publication date
FI880158A (fi) 1988-07-16
SE8700137D0 (sv) 1987-01-15
CA1292684C (en) 1991-12-03
SE8700137L (sv) 1988-07-16
US4888179A (en) 1989-12-19
DK15988D0 (da) 1988-01-14
FI880158A0 (fi) 1988-01-14
EP0277925A1 (en) 1988-08-10
NO880158D0 (no) 1988-01-14
NO880158L (no) 1988-07-18
DK15988A (da) 1988-07-16

Similar Documents

Publication Publication Date Title
SE460945B (sv) En multipel-unit-dos komposition av furosemid
US5508044A (en) Diltiazem pharmaceutical spheroid formulation
US11147772B2 (en) Timed, pulsatile release systems
AU665867B2 (en) Beads having a core coated with an antifungal and a polymer
US5516531A (en) Spherical granules having core and their production
EP1010423B1 (en) Oral pharmaceutical preparation comprising an antiulcer benzimidazole derivative, and process for its production
EP1000615B1 (en) Preparation of pharmaceutically active particles
KR100316206B1 (ko) 모르핀의염을함유하는방출조절식제제
US20170281558A1 (en) Oral pharmaceutical formulation in the form of an aqueous suspension of microcapsules for the modified release of active principle(s).
US6099865A (en) Croscarmellose taste masking
US4798724A (en) Solid, stable dosage forms with an elastic film coating
US20010046964A1 (en) Timed pulsatile drug delivery systems
NO304406B1 (no) Preparat med regulert frigivelse og kapsel omfattende dette
US20070218140A1 (en) Slow-Release Preparations And Their Method Of Production
BG65398B1 (bg) Ентерично покрит фармацевтичен състав и метод за получаване
IE911271A1 (en) Controlled release drug formulation
CN105560209A (zh) 一种治疗心血管疾病的复方制剂及其制备方法
HU201883B (en) Process for producing orally administerable pharmaceutical compositions consisting of composite units and having controlled release of active ingredient
IE910828A1 (en) Long acting granular pharmaceutical composition

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8700137-6

Effective date: 19920806

Format of ref document f/p: F